Type the Characteristics of Pacemaker (PM) Patients Admitted in Stroke Unit: The Stroke Pacemaker Study (SPACES)

References (59)

1. 1 Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. [DOI]
2. 2 Heart Disease: A Textbook of Cardiovascular Medicine. [DOI]
3. 3 Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
4. 4 PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION [DOI]
5. 5 Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction [DOI]
6. 6 Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial [DOI]
7. 7 Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial [DOI]
8. 8 Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation [DOI]
9. 9 Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction [DOI]
10. 10 Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes [DOI]
11. 11 Selecting Patients With Atrial Fibrillation for Anticoagulation [DOI]
12. 12 Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing [DOI]
13. 13 Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation [DOI]
14. 14 A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) [DOI]
15. 15 Atrial Fibrillation and Stroke in the General Medicare Population [DOI]
16. 16 Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk [DOI]
17. 17 Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review [DOI]
18. 18 Stroke prophylaxis in atrial fibrillation: who gets it and who does not? [DOI]
19. 19 A new pacemaker algorithm for the treatment of atrial fibrillation [DOI]
20. 20 Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing [DOI]
21. 21 The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency [DOI]
22. 22 The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients [DOI]
23. 23 Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients [DOI]
24. 24 The World Survey of Cardiac Pacing and Cardioverter Defibrillators: Calendar Year 2001 [DOI]
25. 25 Role of Permanent Pacing to Prevent Atrial Fibrillation [DOI]
26. 26 Update on atrial fibrillation: Part II [DOI]
27. 27 Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study [DOI]
28. 28 Clinical Epidemiology of Atrial Fibrillation and Related Cerebrovascular Events in the United States [DOI]
29. 29 Predictors of stroke in patients paced for sick sinus syndrome [DOI]
30. 30 Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation [DOI]
31. 31 Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association [DOI]
32. 32 Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial [DOI]
33. 33 Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. [DOI]
34. 34 The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: Calendar Year 1997 ‐ Europe [DOI]
35. 35 Predictors and Clinical Impact of Atrial Fibrillation After Pacemaker Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular Pacing [DOI]
36. 36 Treatment of underlying atrial fibrillation: paced rhythm obscures recognition [DOI]
37. 37 Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome [DOI]
38. 38 The role of pacing mode in the development of atrial fibrillation [DOI]
39. 39 Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study [DOI]
40. 40 Prevention Strategies for Cardioembolic Stroke: Present and Future Perspectives~!2009-05-11~!2009-12-23~!2010-06-09~! [DOI]
41. 41 Ischemic stroke after cardiac pacemaker implantation in sick sinus syndrome. [DOI]
42. 42 Atrial Fibrillation and Anticoagulation in Patients with Permanent Pacemakers: Implications for Stroke Prevention [DOI]
43. 43 Therapeutic interventions for prevention of recurrent ischemic stroke.
44. 44 The Results of Pacing Trials for the Prevention and Termination of Atrial Tachyarrhythmias: Is There Any Evidence of Therapeutic Breakthrough? [DOI]
45. 45 Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing [DOI]
46. 46 Permanent ventricular and dual chamber cardiac stimulation: role of pacing mode in relation to chronic atrial fibrillation risk and stroke development [DOI]
47. 47 Approach to and management of the acute stroke patient with atrial fibrillation: A literature review [DOI]
48. 48 Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? [DOI]
49. 49 Cardiac pacing: atrial fibrillation may go unrecognised [DOI]
50. 50 Cardiac Pacing Device Therapy for Atrial Dysrhythmias [DOI]
51. 51 Stroke Prevention in Atrial Fibrillation Study. Final results. [DOI]
52. 52 The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation [DOI]
53. 53 Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study*1 [DOI]
54. 54 QUALITY OF LIFE AND CLINICAL OUTCOMES IN ELDERLY PATIENTS TREATED WITH VENTRICULAR PACING AS COMPARED WITH DUAL-CHAMBER PACING
55. 55 Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction [DOI]
56. 56 Update on Atrial Fibrillation: Part I [DOI]
57. 57 A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the atrial dynamic overdrive pacing trial (ADOPT) [DOI]
58. 58 Prevention Strategies for Cardioembolic Stroke: Present and Future Perspectives [DOI]
59. 59 Atrial fibrillation in the pacemaker clinic.

Cited by 0

No indexed citations yet.

Related research

• The Relationship between Upper Extremity Motor Function and Oral Hygiene among Stroke Survivors: Study Protocol for a Mixed-Method Design — shares topic coverage
• Cognitive Recovery Outcome in a 12 Month Quasi-experimental Study Involving Sub-acute Stroke Survivors in Selected Hospitals in Nnewi, Anambra State, Nigeria — shares topic coverage
• Stroke Awareness and Drug Adherence among Adult Hypertensives in a Tertiary Health Care Centre — shares topic coverage
• The Impact of Upper Limb Functioning on Gait Patterns in Individuals with Post-Stroke Hemiplegia — shares topic coverage
• Circadian Variation of Stroke in a Tertiary Level Hospital — shares topic coverage